Skip to content
Recall Observatory FDA recall evidence

Drug product

Leucovorin Calcium for Injection, equivalent to leucovorin 350 mg/vial (20 mg/mL), Rx Only, FOR IM or IV Use, Sterile, Teva Parenteral Medicines, Inc., Irvine, CA NDC 0703-5145-01; ALSO LABELED UNDER: NOVAPLUS, Manufactured By: Teva Pharmaceuticals USA, Inc., North Wales, PA 19454 NDC 0703-5145-91 (Novaplus, a registered trademark of Vizient, Inc.)

D-0374-2021

April 26, 2021

Class II

Product summary

Firm
Teva Pharmaceuticals USA
Event
Event 87875
Status
Terminated
Classification
Class II
Quantity
192,277 cartons/1 single dose vial per carton
Official record key
drug-enforcement:D-0374-2021

Official wording

Reason: Lack of Assurance of Sterility

Code information: NDC 0703-5145-01: Lot # 31325332B, exp. date 08/2021, Lot # 31325756B, exp. date 09/2021 AND NDC 0703-5145-91: Lot # 31325685B, exp. date 09/2021

Distribution pattern: Product was distributed nationwide.

Derived failure modes

  • Sterility assurance

    reason.sterility_assurance · v1.0.0

    Lack of Assurance of Sterility